Wellcome Trust Sanger Institute (WTSI)
Prof. Soranzo is a human geneticist working in the field of human complex trait genetics. Her research focuses on the application of large-scale genomic analysis to unravel the spectrum of human genetic variation associated with cardiometabolic and immune diseases, and its interaction with non-genetic and environmental cues. Prof. Soranzo graduated in biological sciences at the University of Milano, Italy, with a dissertation on population and evolutionary genetics. She later obtained a PhD in genetics from the University of Dundee, and undertook post-doctoral training in human population and statistical genetics at University College London, conducting applied and methodological work in evolutionary genetics and association studies. In 2005 Prof. Soranzo joined the Pharmacogenomics Department at Johnson & Johnson Pharmaceutical Research and Development (Raritan, USA). In 2007 she joined the Wellcome Trust Sanger Institute, and since 2009 she has led her own team. In 2015 she was additionally appointed as Professor of Human Genetics at the School of Clinical Medicine of the University of Cambridge. Furthermore, Prof. Soranzo is a member of the Cambridge University Platelet Biology and Cardiovascular groups, the NIHR Blood and Transplant Research Unit in Donor Health and Genomics and the EU BLUEPRINT and EpiGeneSys projects. She serves in several steering committees and scientific advisory boards, and is on the editorial board for the European Journal of Human Genetics, Genome Medicine, Trends in Genetics, PLoS Biology and Molecular Biology and Evolution.